Oura’s future is secured.
What’s happening: The smart ring maker closed a $200M Series D, reaching a $5.2B valuation.
Backers included Fidelity Management & Research Company and a previously announced investment from Dexcom.
Oura will deploy funding into product, science, and healthcare innovation, with AI playing a key role.
Closing the loop. Citing the need for “relentless pace of innovation,” Oura had a big 2024.
Optimizing its hardware, it launched a more accurate Gen 4 ring — while adding new features, acquiring metabolic health platform Veri and movement health specialist Sparta Science, and integrating with Dexcom CGMs.
Accelerating growth, CEO Tom Hale hinted at more acquisitions to come.
“We know that ŌURA has the potential to change lives at scale, and we’re excited to continue leading the market in innovation while pursuing opportunities that extend beyond the ring.”
Looking ahead: As Ultrahuman and Samsung give chase, Oura is following Apple’s blueprint by developing an integrated health ecosystem.
